Life-science briefing: Friday, March 28, 2008
TODAY’S HEADLINES:
VaxGen, Raven Bio terminate merger agreement (release)
Aerovance gets $20M in venture debt for respiratory disease (release)
EKOS raises $5M for ultrasound catheters (peHUB)
Intelligent Bio-Systems draws $353K for high-speed genome sequencing (peHUB)
Quintessence Bio takes in $5M for cancer-directed proteins (VentureWire)
7 Health Ventures adds three members to investment team (release)
Contract manufacturer Cytovance names Darren Head CEO (release)
VaxGen, Raven Bio terminate merger agreement – A weirdly structured, always hard-to-understand merger between the failed vaccine biotech VaxGen and startup Raven Biotechnologies… Continue Reading